https://www.medscape.com/viewarticle/907432

13 0 Report

The US Food and Drug Administration (FDA) has cleared for marketing the Embrace smartwatch (Empatica Inc) for seizure tracking in children as young as age 6. The Embrace smartwatch detects patterns in motion and physiological signals that may be associated with generalized tonic-clonic seizures , and immediately alerts caregivers. It was approved by the FDA for use in adults last February, as reported by Medscape Medical News . "The clearance of the Embrace watch to detect seizures in children ages 6 years and older is an important step forward in our ability to identify seizures rapidly and thereby allow parents or others to respond," Orrin Devinsky, MD, director at NYU Comprehensive Epi... Full story

3 days ago, 13 January

0
wait